Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Justice Department Intervenes in Whistleblower Suits Against Omnicare

Jaclyn Jaeger | December 24, 2014

The Department of Justice this week announced that it has intervened in two consolidated whistleblower lawsuits against drug company Omnicare over allegations that it solicited and received millions of dollars in kickbacks from drug maker Abbott Laboratories.

The two cases, United States ex rel. Spetter v. Abbott Labs  and United States ex rel. McCoyd v. Abbott Labs, were filed in the Western District of Virginia under the whistleblower provisions of the False Claims Act, which allow private parties to sue on behalf of the government for the submission of false claims for government funds and to receive a share of any recovery. The FCA also permits the government to intervene in such lawsuits, as it has done in this case.

“Although the United States Attorney’s Office for the Western District of Virginia is...

Buy this article for $49, or subscribe to Compliance Week for a month at $149 and get unlimited article access for 30 days.